Electrophysiological Investigations of the Effects of a Subanesthetic Dose of Ketamine on Monoamine Systems

Electrophysiological Investigations of the Effects of a Subanesthetic Dose of Ketamine on Monoamine Systems

Show other versions (1)

Ketamine is a non-competitive NMDA antagonist that has been shown to have antidepressant properties both clinically as well as in preclinical studies when administered at a subanesthetic dose. In vivo electrophysiological recordings were carried in male Sprague Dawley rats 30 minutes following keta...

Full description

Bibliographic Details
Main Author:	El Iskandarani, Kareem S.
Other Authors:	Blier, Pierre
Language:	en
Published:	Université d'Ottawa / University of Ottawa 2014
Subjects:	Ketamine Major depressive disorder Monoamines Glutamate AMPA NMDA
Online Access:	http://hdl.handle.net/10393/30379 http://dx.doi.org/10.20381/ruor-3466

Similar Items

Electrophysiological Investigations of the Effects of a Subanesthetic Dose of Ketamine on Monoamine Systems
by: El Iskandarani, Kareem S.
Published: (2014)

EFFECT OF SINGLE DOSE OF KETAMINE IN PATIENTS OF MAJOR DEPRESSIVE DISORDER-A PAKISTANI PERSPECTIVE
by: Muhammad Siddique Kakar, et al.
Published: (2020-10-01)

Ketamine: Neuroprotective or Neurotoxic?
by: Divya Choudhury, et al.
Published: (2021-09-01)

Ketamine in affective disorders – expectations and limitations
by: Ewelina Soroka, et al.
Published: (2019-07-01)

Ketamine: A New Antidepressant?
by: Feride Karacaer
Published: (2015-03-01)

Ketamine for depression : The role of dissociative effects
by: Broström, Jakob
Published: (2020)

Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
by: Vasilescu AN, et al.
Published: (2017-03-01)

Efficacy of different doses of ketamine as a bolus in major depressive disorder
by: Farzan Kheirkhah, et al.
Published: (2018-05-01)

Ketamine for treatment-resistant depression : Moving away from conventional antidepressants
by: Blom, Emma-Clara
Published: (2021)

Новый взгляд на патогенез депрессии: возможно ли появление быстродействующих антидепрессантов?
by: Мосолов, С.Н., et al.
Published: (2020-10-01)

Ketamine and Calcium Signaling—A Crosstalk for Neuronal Physiology and Pathology
by: Malwina Lisek, et al.
Published: (2020-11-01)

Safety of Repeated Administration of Parenteral Ketamine for Depression
by: David Feifel, et al.
Published: (2020-07-01)

Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors
by: Takahisa Hanada
Published: (2020-03-01)

Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area.
by: Charles eDucrot, et al.
Published: (2013-10-01)

Investigation of the Mechanisms of Action of Ketamine on the Monoamine Systems: Electrophysiological Studies on the Rat Brain
by: Iro, Chidiebere Michael
Published: (2019)

Ketamine may block NMDA receptors in astrocytescausing a rapid antidepressant effect
by: Bernhard J Mitterauer
Published: (2012-12-01)

Subcutaneous Ketamine in Depression: A Systematic Review
by: Vitor Breseghello Cavenaghi, et al.
Published: (2021-05-01)

Ketamine and depression: a narrative review
by: Corriger A, et al.
Published: (2019-08-01)

A review of ketamine’s role in ECT and non-ECT settings
by: Jankauskas V, et al.
Published: (2018-06-01)

Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients—A randomized, double‐blind, controlled clinical study
by: Lei Zou, et al.
Published: (2021-01-01)

Repeated dose of ketamine effect to the rat hippocampus tissue
by: Mehtap Okyay Karaca, et al.
Published: (2015-01-01)

Associations Among Monoamine Neurotransmitter Pathways, Personality Traits, and Major Depressive Disorder
by: Xiaojun Shao, et al.
Published: (2020-05-01)

Clinical features of epileptic syndrome and alteration of NMDAand of AMPA-receptors of glutamate in the pathogenesis of the disease in the patients with supratentorial meningiomas of the brain
by: V. N. Ochkolyas, et al.
Published: (2018-12-01)

Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors
by: Suzanne M. Underhill, et al.
Published: (2007-02-01)

Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
by: Domenico De Berardis, et al.
Published: (2018-09-01)

Differentiating Medicated Patients Suffering from Major Depressive Disorder from Healthy Controls by Spot Urine Measurement of Monoamines and Steroid Hormones
by: Chandra S. Wijaya, et al.
Published: (2018-04-01)

Castration of Dogs Using Local Anesthesia After Sedating With Xylazine and Subanesthetic Doses of Ketamine
by: Erika Silva, et al.
Published: (2020-01-01)

Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study
by: Leo R. Silberbauer, et al.
Published: (2020-09-01)

The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture
by: Todd F. Glass, et al.
Published: (2004-12-01)

Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?
by: Rajarshi Guha Thakurta, et al.
Published: (2012-01-01)

Rapid response with ketamine on suicidal cognition in resistant depression
by: Rajarshi Guha Thakurta, et al.
Published: (2012-01-01)

Ketamine administered to pregnant rats in the second trimester causes long-lasting behavioral disorders in offspring
by: Tianyun Zhao, et al.
Published: (2014-08-01)

Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla
by: Petr Bednarik, et al.
Published: (2021-03-01)

Serotonin Transporter and Plasma Membrane Monoamine Transporter Are Necessary for the Antidepressant-Like Effects of Ketamine in Mice
by: Melodi A. Bowman, et al.
Published: (2020-10-01)

A Major Role for the Lateral Habenula in Depressive Illness: Physiologic and Molecular Mechanisms
by: Philip W. Gold, et al.
Published: (2019-05-01)

Mécanisme d'action antidépresseur rapide de la kétamine et de son principal métabolite (2R,6R)-hydroxynorkétamine : rôle de la balance excitation-inhibition chez la souris
by: Pham, Thu Ha
Published: (2018)

Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
by: Acevedo-Diaz, E.E, et al.
Published: (2022)

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
by: Szarmach J, et al.
Published: (2020-10-01)

Cognitive protective effect of subanesthetic ketamine anesthesia on elderly patients with depression undergoing electroconvulsive therapy: a prospective controlled clinical study
by: ZOU Lei, et al.
Published: (2021-02-01)

Clinical case of postoperative anesthesia of a patient by using subanesthetic dose of ketamine in severe abdominal pathology
by: B V Zaletskyi, et al.
Published: (2019-06-01)